ArticleClinical ophthalmology (Auckland, N.Z.)2025
Efficacy and Safety of Switching from Ranibizumab to Brolucizumab in Age-Related Macular Degeneration: Multicenter Real-World Outcomes.
Libor Hejsek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.